PRAX
Praxis Precision Medicines, Inc.
Stock
$295.51+8.60 (+3.00%)Close Oct 2, 2026
Balance sheet
| Line | Q2 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Cash and short-term investments | $1.4B | $926M | $470M | $0 | $100M | $276M | $297M | $45M |
| Current assets | $772M | $611M | $404M | $85M | $111M | $287M | $302M | $45M |
| Intangible assets | $773K | $0 | — | — | — | — | — | — |
| Total assets | $1.4B | $938M | $483M | $88M | $115M | $293M | $303M | $48M |
| Current liabilities | $49M | $60M | $38M | $16M | $34M | $38M | $16M | $6.8M |
| Total liabilities | $49M | $60M | $38M | $18M | $39M | $42M | $16M | $7.6M |
| Shareholders' equity | $1.3B | $878M | $445M | $70M | $76M | $251M | $287M | −$81M |
| Shares outstanding | 27.9M | 27.9M | 20.2M | 13.2M | 3.5M | 3.0M | 2.6M | — |
| Current ratio | 15.73 | 10.22 | 10.77 | 5.39 | 3.23 | 7.48 | 19.23 | 6.67 |